Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor

NCT01992952 is registered in ClinicalTrials.gov with Velindre NHS Trust as lead sponsor.

NCT NCT01992952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Randomised Placebo Controlled Trial of Fulvestrant +/- AZD5363 in Postmenopausal Women With Advanced Breast Cancer Previously Treated With a Third Generation Aromatase Inhibitor
Lead sponsor
Velindre NHS Trust
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 7, 2014
Completion date
December 31, 2025
Enrollment
149 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor positive breast cancer